Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue

Objective: To compare the expression of TAK1 in normal myometrium and uterine leiomyoma tissue, and explore the relationship between these molecules and pathogenesis of uterine leiomyoma. Methods: Formaldehyde-fixed, paraffin-embedded specimen from 76 patients with uterine leiomyoma and normal my...

Full description

Bibliographic Details
Main Authors: Xiao-Ping Chen, Li Zhao
Format: Article
Language:English
Published: Editorial Board of Journal of Hainan Medical University 2016-03-01
Series:Journal of Hainan Medical University
Subjects:
Online Access:http://www.jhmuweb.net/PDF/201606/20.pdf
id doaj-ac97649d725e47f092ea7c50723c721f
record_format Article
spelling doaj-ac97649d725e47f092ea7c50723c721f2020-11-24T22:30:07ZengEditorial Board of Journal of Hainan Medical UniversityJournal of Hainan Medical University1007-12371007-12372016-03-012267072Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissueXiao-Ping Chen0Li Zhao1Department of Obstetrics and Gynecology, Xi'an Sports Trauma Hospital, Xi'an 710068,Shaanxi Province, ChinaDepartment of Obstetrics and Gynecology, Xi'an Sports Trauma Hospital, Xi'an 710068,Shaanxi Province, ChinaObjective: To compare the expression of TAK1 in normal myometrium and uterine leiomyoma tissue, and explore the relationship between these molecules and pathogenesis of uterine leiomyoma. Methods: Formaldehyde-fixed, paraffin-embedded specimen from 76 patients with uterine leiomyoma and normal myometrium adjacent were obtained from our hospital. The expression of TAK1 was detected by immunohistochemical staining and PCR analysis. Results: The expression of protein and mRNA levels TAK1 in uterine leiomyoma tissues were significantly increased when compared with normal myometrium, but not related to the number of leiomyoma. Furthermore, TAK1 expression was associated with the size of uterine leiomyoma. Conclusion: The present results suggest that the abundant expression of TAK1 protein may have a molecular basis characteristic of leiomyomas in the human uterus, and TAK1 may be a therapeutic target for the treatment of uterine leiomyoma.http://www.jhmuweb.net/PDF/201606/20.pdfUterine leiomyomaTAK1
collection DOAJ
language English
format Article
sources DOAJ
author Xiao-Ping Chen
Li Zhao
spellingShingle Xiao-Ping Chen
Li Zhao
Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
Journal of Hainan Medical University
Uterine leiomyoma
TAK1
author_facet Xiao-Ping Chen
Li Zhao
author_sort Xiao-Ping Chen
title Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
title_short Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
title_full Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
title_fullStr Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
title_full_unstemmed Expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
title_sort expression and significance of transforming growth factor β-activated kinase 1 in uterine myoma tissue
publisher Editorial Board of Journal of Hainan Medical University
series Journal of Hainan Medical University
issn 1007-1237
1007-1237
publishDate 2016-03-01
description Objective: To compare the expression of TAK1 in normal myometrium and uterine leiomyoma tissue, and explore the relationship between these molecules and pathogenesis of uterine leiomyoma. Methods: Formaldehyde-fixed, paraffin-embedded specimen from 76 patients with uterine leiomyoma and normal myometrium adjacent were obtained from our hospital. The expression of TAK1 was detected by immunohistochemical staining and PCR analysis. Results: The expression of protein and mRNA levels TAK1 in uterine leiomyoma tissues were significantly increased when compared with normal myometrium, but not related to the number of leiomyoma. Furthermore, TAK1 expression was associated with the size of uterine leiomyoma. Conclusion: The present results suggest that the abundant expression of TAK1 protein may have a molecular basis characteristic of leiomyomas in the human uterus, and TAK1 may be a therapeutic target for the treatment of uterine leiomyoma.
topic Uterine leiomyoma
TAK1
url http://www.jhmuweb.net/PDF/201606/20.pdf
work_keys_str_mv AT xiaopingchen expressionandsignificanceoftransforminggrowthfactorbactivatedkinase1inuterinemyomatissue
AT lizhao expressionandsignificanceoftransforminggrowthfactorbactivatedkinase1inuterinemyomatissue
_version_ 1725741902164131840